Natco Pharma Q2 Net Profit Declines 60.8% to Rs 202.6 Cr

New Delhi: Natco Pharma on Friday posted a 60.8 per cent decline in consolidated net profit to Rs 202.6 crore during the September quarter, weighed down by a fall in revenues.

The pharma company had reported a net profit of Rs 517.9 crore in the corresponding period of the preceding fiscal.

Its revenue from operations declined to Rs 967.3 crore in the second quarter of FY27 from Rs 1,363 crore a year ago, the company said in a regulatory filing.

Total expenses stood at Rs 776.2 crore, down from Rs 849.3 crore a year ago, it said.

During the quarter, Natco acquired an additional 13.25 per cent stake in Adcock Ingram Holding Ltd.

In the first half of the current fiscal (H1 FY27), Natco Pharma posted a 59 per cent decline in net profit to Rs 409.1 crore from Rs 998.2 crore in the April-September period of the preceding financial year.

The company’s board of directors also approved an interim dividend of Rs 1.25 per equity share of Rs 2 each during the quarter under review.

Shares of Natco Pharma closed 0.22 per cent lower at Rs 807 apiece on the BSE.

(Disclaimer: Except for the headline, this article has not been edited by HDFC Sky editorial team and is auto-generated from PTI feed.)